Ex Vivo Drug Response Platform From KYAN Shows Clinical Utility in Non-Hodgkin Lymphoma Patients July 28, 2025
KYAN Technologies to Present New Data on Optim.AI™ Immunotherapy and Real-World Pan-Cancer Utility at AACR 2025 April 15, 2025
Study Validates Effectiveness of KYAN Tech’s Platform for Combination Therapy Prediction and Target Discovery in Sarcoma March 25, 2025
Mayo Clinic Laboratories and KYAN Technologies enter a collaboration to expand patients’ access to cancer testing March 14, 2025
KYAN Technologies to Present Functional Combinatorial Precision Medicine Platform Data at 2023 AACR-NCI-EORTC Conference October 10, 2023
KYAN Technologies Announces Presentation at the 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer November 14, 2023
KYAN Technologies to Present AML Concordance Data at the 65th ASH Annual Meeting and Exposition December 04, 2024
KYAN Technologies to Present New Data in Oral Minisymposium and Posters at AACR 2024 Annual Meeting March 26, 2024
KYAN Technologies to Present New Data at 2024 Rivkin Center and AACR Ovarian Cancer Research Symposium September 17, 2024
